Correlation of granuloma structure with clinical outcome defines two types of idiopathic disseminated BCG infection

Journal of Pathology

Volumn 181, Issue 1, 1997, Pages 25-30

  Emile, Jean François ^a   Patey, Natacha ^a   Altare, Frédéric ^a   Lamhamedi, Salma ^a   Jouanguy, Emmanuelle ^a   Boman, François ^b   Quillard, Janine ^c   Lecomte Houcke, Martine ^d   Verola, Olivier ^e   Mousnier, Jean Françoise ^f   Dijoud, Frédérique ^g   Blanche, Stéphane ^a   Fischer, Alain ^a   Brousse, Nicole ^a   Casanova, Jean Laurent ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b CHU NANCY BRABOIS   (France)

^c BICÊTRE HOSPITAL   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e SAINT LOUIS HOSPITAL   (France)

^f UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^g EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

BCG; granuloma; idiopathic; immunodeficiency; infection

Indexed keywords

BCG VACCINE;

ARTICLE; CHILD; CLINICAL ARTICLE; GRANULOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; TUBERCULOSIS; VACCINATION;

BCG VACCINE; CHILD; GRANULOMA; HUMANS; MYCOBACTERIUM BOVIS; PROGNOSIS; RETROSPECTIVE STUDIES; TUBERCULOSIS;

EID: 0031038855     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199701)181:1<25::AID-PATH747>3.0.CO;2-Z     Document Type: Article

References (36)

1. Fine PEM. BCG vaccine: a rough guide. Clin Inf Dis 1995; 20: 11.
2. Who scientific group. Report on primary immunodeficiency diseases. Clin Exp Immunol 1995; 99,S1: 1.
3. Casanova JL, Jouanguy E, Lamhamedi S, Blanche S, Fischer A. Immunologic conditions of children with Bacillus Calmette-Guérin (BCG) disseminated infection. Lancet 1995; 346: 581.
4. Casanova JL, Blanche S, Emile JF, et al. Idiopathic disseminated BCG infection: a French national retrospective study. Pediatrics 1996; 98: 774.
5. Meyer J, Jensen KA. A fatal case of tuberculosis produced by BCG. Am Rev Tuberc 1954; 70: 402.
6. Imerslund O, Jonsen T. Lupus vulgaris and multiple bone lesions caused by BCG. Acta Tub Scand 1954; 30: 115.
7. Thrap-Meyer H. Generalized BCG infection in man. I. Clinical report. Acta Tub Scand 1954; 29: 173-179.
8. Waaler E, Oeding P. Generalized BCG infection in man. Autopsy findings. Acta Tub Scand 1954; 29: 187.
9. Dvoracek C, Mores A, Neoral L. Generalizovana lymfadenopatie po BCG vakcinaci. Rozhledy v tuberkulose a v nemocech plicnich. (Czechoslovakia) 1959; 19: 107.
10. Sacrez R, Levy M, Reys P, Kirsch W, Lahlou B. Dissémination de bacille tuberculeux bovin après administration à un enfant de 6 ans de BCG. Lésions cutanées, osseuses et ganglionnaires multiples. Pédiatrie 1967; 22: 435.
11. Watanabe T, Tanaka K, Hagiwara Y. Generalized tuberculosis after BCG vaccination. Report of an autopsy case. Acta Pathol Jpn 1969; 19: 395.
12. Ulgenalp I, Yalcin C, Cetiner M, Ozgen N, Koseli I. Olumle sonuclanan jeneralize BCG infeksiyonu. Tuberculoz ve Toraks 1973; 21: 11. (Turkey).
13. Gerbeaux J, Baculard A, Sultan C, Dresh C, Bonnet M. Bécégite des organes hématopoïétiques avec déficit de l'immunité à médiation cellulaire. Arch Fr Pediatr 1974; 31: 463.
14. Heyne K. Generalisatio BCG familiaris semibenigna, Osteomyelitis salmonellosa und Pseudotuberculosis intestinalis - Folgen eines familiären Makrophagendefektes? Europ J Pediatr 1976; 121: 179.
15. Passwell J, Katz D, Frank Y, Spirer Z, Cohen BE, Ziprkowski M. Fatal disseminated BCG infection. An investigation of the immunodeficiency. Am J Dis Child 1976; 130: 433.
16. Doleckova V, Viklicky J, Sula L, Kubecova D. Fatal generalized BCG histiocytosis. Tubercle 1977; 58: 13.
17. Haveric D, Stancic D, Lazarevic B, Vidovic Z. Fatalna generalizirana tuberculoza izazvana BCG vakcinom. Jug Pedijat 1977; 20: 221.
18. Matusima M, Masumara Y, Kimura T, Sato K, Takahashi H. A case of generalized infection with low virulent tubercle bacilli indistinguishable from BCG showing proliferation of histiocytes loading numerous bacilli without epithelioid granuloma. Kekkaku 1978; 53: 575.
19. Pedersen FK, Engbaek HC, Hertz H, Vergman B. Fatal BCG infection in an immunocompetent girl. Acga Paediatr Scand 1978; 67: 519.
20. Torriani R, Zimmermann A, Morell A. Die BCG-sepsis als letale Komplikation der BCG-Impfung. Schweiz med Wschr (Switzerland) 1979; 109: 708.
21. Mackay A, Alcorn MJ, Macleod IM, et al. Fatal disseminated BCG infection in an 18-year-old boy. Lancet 1980; 27: 1332.
22. Catanzaro A, Melish ME, Minkoff DI. Disseminated BCG infection. J Pediatr 1981; 99: 268.
23. Katzir Z, Okon E, Ludmirski A, Sherman Y, Haas H. Generalized lymphadenitis following BCG vaccination in an immunocompetent 12-year-old boy. Eur J Pediatr 1984; 141: 165.
24. Molz G, Hartmann HP, Griesser HR. Generalisierte BCG-infektion bei einem 7 wochen alten, plötslich gestorben säugling. Pathologe 1986; 7: 216.
25. Abramowsky C, Gonzalez B, Sorensen RU. Disseminated bacillus calmette-Guérin infections in patients with primary immunodeficiencies. Am J Clin Pathol 1993; 100: 52.
26. Gonzalez B, Moreno S, Burdach R, et al. Clinical presentation of Bacillus Calmette-Guérin infections in patients with immunodeficiency syndromes. Pediatr Infect Dis 1989; 8: 201.
27. Ehrengut W. BCG-itis während der kindheit und in der Schwangerschaft. Zugleich ein Beitrag zu einer BCG-bedingten nekrotisierenden zerebralen arteritis. Klin Pädiatr 1990; 202: 303.
28. Lucas SB. Histopathology of leprosy and tuberculosis - an overview. Brit Med Bull 1988; 44: 584.
29. Vidal S, Tremblay ML, Govoni G, et al. The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nrampl gene. J Exp Med 1995; 182: 655.
30. Pelletier M, Forget A, Bourassa D, Gros P, Skamene E. Immunopathology of BCG infection in genetically resistant and suceptible mouse strains. J Immunol 1982; 129: 2179.
31. Gordon S, Keshav S, Stein M. BCG-induced granuloma formation in murine tissues. Immunobiology 1994; 191: 369.
32. 32a. Kindler V, Sappino AP, Grau GE, Piguet PF, Vassalli P. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 1989; 56: 731.
33. 32b. Flynn JL, Goldstein, MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ, Schreiber R, Mak TW, Bloom BR. Tumor necrosis factor α is required in the protective immune response against mycobacterium tuberculosis in mice. Immunity 1995; 2: 561.
34. Kamijo R, Le J, Shapiro D, et al. Mice that lack the Interferon-γ receptor have profoundly altered response to infection with bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide. J Exp Med 1993; 178: 1435.
35. Kamijo R, Harada H, Matsuyama T, et al. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 1994; 263: 1612.
36. Levin M, Newport M, D'Souza S, et al. Familial disseminated atypical mycobacterial infection in childhood: a human mycobacterial susceptibility gene? Lancet 1995; 345: 79-83.